Showing results (1101-1110 of 1,170) with videos related to
Sort By:
Pageof 117
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2017
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRIRafal Panek, Liam Welsh, Lauren C J Baker, et al.Clinical Pharmacology and Therapeutics|May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human PharmacokineticsUsman Arshad, Henry Pertinez, Helen Box, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith Kr Rajoli, Henry Pertinez, Usman Arshad, et al.Journal of Surgical Oncology|August 21, 2024
Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional analysisHaleh Amirian, Erin Dickey, Ifeanyichukwu Ogobuiro, et al.Oncogene|January 22, 2019
KLF9-dependent ROS regulate melanoma progression in stage-specific mannerArchis Bagati, Sudha Moparthy, Emily E Fink, et al.Journal of Medicinal Chemistry|May 14, 2010
Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approachPanayiotis A Procopiou, Victoria J Barrett, Nicola J Bevan, et al.Molecular Cancer Therapeutics|July 9, 2009
Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941Florence I Raynaud, Suzanne A Eccles, Sonal Patel, et al.Cell Stem Cell|May 5, 2018
Retinoid-Sensitive Epigenetic Regulation of the Hoxb Cluster Maintains Normal Hematopoiesis and Inhibits LeukemogenesisPengxu Qian, Bony De Kumar, Xi C He, et al.Cancer Research|August 15, 2008
CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cellsDavid Krige, Lindsey A Needham, Lindsay J Bawden, et al.British Journal of Clinical Pharmacology|October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.Pageof 117